688016 心脉医疗
已收盘 08-28 15:00:01
资讯
新帖
简况
心脉医疗（688016）2026年中报简析：营收净利润同比双双增长，公司应收账款体量较大
证券之星 · 08-28 06:16
心脉医疗（688016）2026年中报简析：营收净利润同比双双增长，公司应收账款体量较大
股市必读：心脉医疗新发布《心脉医疗：关于2026年半年度利润分配预案的公告》
证券之星 · 08-27 05:10
股市必读：心脉医疗新发布《心脉医疗：关于2026年半年度利润分配预案的公告》
图解心脉医疗中报：第二季度单季净利润同比下降9.45%
证券之星 · 08-27 01:55
图解心脉医疗中报：第二季度单季净利润同比下降9.45%
微创医疗：心脉医疗科技上半年归母净利润3.22亿元 同比增加2.45%
同花顺 · 08-26 22:11
微创医疗：心脉医疗科技上半年归母净利润3.22亿元 同比增加2.45%
股市必读：心脉医疗（688016）6月26日董秘有最新回复
证券之星 · 06-29
股市必读：心脉医疗（688016）6月26日董秘有最新回复
心脉医疗：公司各生产基地产能利用率保持较高水平
证券之星 · 06-26
心脉医疗：公司各生产基地产能利用率保持较高水平
每周股票复盘：心脉医疗（688016）每股派现1.00元（含税）
证券之星 · 05-31
每周股票复盘：心脉医疗（688016）每股派现1.00元（含税）
心脉医疗（688016）披露2025年年度权益分派实施公告，5月29日股价下跌0.47%
证券之星 · 05-29
心脉医疗（688016）披露2025年年度权益分派实施公告，5月29日股价下跌0.47%
每周股票复盘：心脉医疗（688016）2025年年度股东会顺利召开
证券之星 · 05-17
每周股票复盘：心脉医疗（688016）2025年年度股东会顺利召开
心脉医疗（688016）披露2025年年度股东会决议公告，5月14日股价下跌2.27%
证券之星 · 05-14
心脉医疗（688016）披露2025年年度股东会决议公告，5月14日股价下跌2.27%
【机构调研记录】蜂巢基金调研心脉医疗
证券之星 · 05-01
【机构调研记录】蜂巢基金调研心脉医疗
【机构调研记录】东海基金调研爱博医疗、心脉医疗
证券之星 · 05-01
【机构调研记录】东海基金调研爱博医疗、心脉医疗
心脉医疗(688016)3月31日股东户数1.63万户，较上期增加6.47%
证券之星 · 04-30
心脉医疗(688016)3月31日股东户数1.63万户，较上期增加6.47%
图解心脉医疗一季报：第一季度单季净利润同比增长19.44%
证券之星 · 04-30
图解心脉医疗一季报：第一季度单季净利润同比增长19.44%
微创医疗(00853)：心脉医疗科技第一季度股东应占净利润1.55亿元 同比增加19.44%
智通财经 · 04-29
微创医疗(00853)：心脉医疗科技第一季度股东应占净利润1.55亿元 同比增加19.44%
股市必读：心脉医疗（688016）4月3日披露最新机构调研信息
证券之星 · 04-07
股市必读：心脉医疗（688016）4月3日披露最新机构调研信息
【机构调研记录】蜂巢基金调研心脉医疗
证券之星 · 04-06
【机构调研记录】蜂巢基金调研心脉医疗
【机构调研记录】红塔红土调研心脉医疗
证券之星 · 04-06
【机构调研记录】红塔红土调研心脉医疗
【机构调研记录】惠升基金调研道恩股份、心脉医疗等3只个股（附名单）
证券之星 · 04-06
【机构调研记录】惠升基金调研道恩股份、心脉医疗等3只个股（附名单）
每周股票复盘：心脉医疗（688016）Q4净利增362.05%、股东户数降4.41%
证券之星 · 04-05
每周股票复盘：心脉医疗（688016）Q4净利增362.05%、股东户数降4.41%
公司概况
公司名称：
上海微创心脉医疗科技(集团)股份有限公司
所属行业：
专用设备制造业
上市日期：
2019-07-22
主营业务：
上海微创心脉医疗科技(集团)股份有限公司的主营业务是主动脉及外周血管介入医疗器械的研发、生产、销售和服务。公司的主要产品是胸主动脉和腹主动脉覆膜支架、术中支架、外周血管支架、药物球囊扩张导管、球囊扩张导管、腔静脉滤器及滤器回收器、血栓切除装置、肿瘤栓塞微球。公司获得了2025上海专精特新企业品牌价值100强称号。
发行价格：
46.23
{"stockData":{"symbol":"688016","market":"SH","secType":"STK","nameCN":"心脉医疗","latestPrice":90.43,"timestamp":1787900401000,"preClose":90.84,"halted":0,"volume":1344111,"delay":0,"changeRate":-0.0045,"floatShares":123000000,"shares":123000000,"eps":4.6328,"marketStatus":"已收盘","change":-0.41,"latestTime":"08-28 15:00:01","open":90.8,"high":91.79,"low":90.11,"amount":122000000,"amplitude":0.0185,"askPrice":90.44,"askSize":2,"bidPrice":90.43,"bidSize":1,"shortable":0,"etf":0,"ttmEps":4.6328,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788139800000},"marketStatusCode":5,"adr":0,"adjPreClose":90.84,"symbolType":"stock_kcb","openAndCloseTimeList":[[1787880600000,1787887800000],[1787893200000,1787900400000]],"highLimit":99.92,"lowLimit":81.76,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":123262117,"isCdr":false,"pbRate":2.62,"roa":"--","peRate":19.519513,"roe":"7.66%","epsLYR":4.65,"committee":0.225225,"marketValue":11147000000,"turnoverRate":0.0109,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-08-31。","afterMarket":{"amount":27129,"volume":300,"close":90.43,"buyVolume":0,"sellVolume":3143,"time":1787902437746,"indexStatus":"已收盘 08-28 15:30:00","preClose":90.84},"floatMarketCap":11147000000},"requestUrl":"/m/hq/s/688016/wiki","defaultTab":"wiki","newsList":[{"id":"2662360900","title":"心脉医疗（688016）2026年中报简析：营收净利润同比双双增长，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2662360900","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662360900?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:16","pubTimestamp":1787869005,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期心脉医疗发布2026年中报。截至本报告期末，公司营业总收入7.94亿元，同比上升11.13%，归母净利润3.22亿元，同比上升2.45%。本报告期心脉医疗公司应收账款体量较大，当期应收账款占最新年报归母净利润比达80.67%。去年的净利率为41.07%，算上全部成本后，公司产品或服务的附加值极高。本文数据来源于心脉医疗2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800010888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662747816","title":"股市必读：心脉医疗新发布《心脉医疗：关于2026年半年度利润分配预案的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662747816","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662747816?lang=zh_cn&edition=full","pubTime":"2026-08-27 05:10","pubTimestamp":1787778623,"startTime":"0","endTime":"0","summary":"截至2026年8月26日收盘，心脉医疗报收于92.21元，上涨0.9%，换手率0.95%，成交量1.17万手，成交额1.08亿元。公司公告汇总：拟以实施权益分派股权登记日总股本扣减回购专用证券账户股份为基数，向全体股东每10股派发现金红利13.00元（含税）。公司公告汇总：2026年半年度营业总收入79,394.90万元，同比增长11.13%；归母净利润32,236.24万元，同比增长2.45%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700010156.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662760746","title":"图解心脉医疗中报：第二季度单季净利润同比下降9.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662760746","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662760746?lang=zh_cn&edition=full","pubTime":"2026-08-27 01:55","pubTimestamp":1787766925,"startTime":"0","endTime":"0","summary":"证券之星消息，心脉医疗2026年中报显示，上半年度公司主营收入7.94亿元，同比上升11.13%；归母净利润3.22亿元，同比上升2.45%；扣非净利润2.99亿元，同比上升10.45%；其中2026年第二季度，公司单季度主营收入4.24亿元，同比上升10.85%；单季度归母净利润1.68亿元，同比下降9.45%；单季度扣非净利润1.48亿元，同比下降0.01%；负债率13.72%，投资收益642.83万元，财务费用564.63万元，毛利率71.36%。财报数据概要请见下图:本文数据来源于心脉医疗2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700005739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662108247","title":"微创医疗：心脉医疗科技上半年归母净利润3.22亿元 同比增加2.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662108247","media":"同花顺","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662108247?lang=zh_cn&edition=full","pubTime":"2026-08-26 22:11","pubTimestamp":1787753460,"startTime":"0","endTime":"0","summary":"微创医疗(00853)发布公告，公司附属公司上海微创心脉医疗科技(集团)股份有限公司(心脉医疗科技)截至2026年6月30日止6个月取得收入人民币7.94亿元，同比增加11.13%;归属于心脉医疗科技股权持 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260826/c679319386.shtml","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260826/c679319386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["688016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647343471","title":"股市必读：心脉医疗（688016）6月26日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2647343471","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647343471?lang=zh_cn&edition=full","pubTime":"2026-06-29 03:34","pubTimestamp":1782675252,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，心脉医疗报收于86.08元，下跌2.8%，换手率1.09%，成交量1.34万手，成交额1.16亿元。董秘最新回复投资者： 公司一季报的毛利率上升很多，请问具体是哪类产品的毛利率上升较快?年报显示公司国内业务毛利率超 70%，海外业务毛利率已提升至 60% 以上。当日关注点交易信息汇总：6月26日主力资金净流出802.82万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900001106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646353226","title":"心脉医疗：公司各生产基地产能利用率保持较高水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2646353226","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646353226?lang=zh_cn&edition=full","pubTime":"2026-06-26 17:30","pubTimestamp":1782466241,"startTime":"0","endTime":"0","summary":"证券之星消息，心脉医疗(688016)06月26日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司的产能利用率是多少？订单情况如何？前几年公司的产能利用率都超过100%，如今是什么限制了公司销售收入的增加？心脉医疗回复：尊敬的投资者您好，公司各生产基地产能利用率保持较高水平，能够满足订单需求，公司2025年年度、2026年第一季度营业收入均同比增长，公司将持续积极推进产能配套建设，提升产线运营效率，挖掘长期增长空间，感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600032037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639604426","title":"每周股票复盘：心脉医疗（688016）每股派现1.00元（含税）","url":"https://stock-news.laohu8.com/highlight/detail?id=2639604426","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639604426?lang=zh_cn&edition=full","pubTime":"2026-05-31 03:53","pubTimestamp":1780170790,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，心脉医疗报收于102.14元，较上周的99.37元上涨2.79%。本周关注点公司公告汇总：心脉医疗每股派发现金红利1.00元（含税），股权登记日为2026年6月4日。公司以实施权益分派股权登记日总股本扣减回购股份后的数量为基数，每10股派发现金红利10元（含税）。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100001141.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639646675","title":"心脉医疗（688016）披露2025年年度权益分派实施公告，5月29日股价下跌0.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2639646675","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639646675?lang=zh_cn&edition=full","pubTime":"2026-05-29 22:35","pubTimestamp":1780065316,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，心脉医疗报收于102.14元，较前一交易日下跌0.47%，最新总市值为125.9亿元。该股当日开盘102.6元，最高104.58元，最低100.53元，成交额达2.29亿元，换手率为1.81%。近日，心脉医疗发布《2025年年度权益分派实施公告》。公告显示，公司2025年年度权益分派方案为：每股派发现金红利1.00元（含税）；股权登记日为2026年6月4日，除权（息）日为2026年6月5日，现金红利发放日为2026年6月5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900046495.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636406422","title":"每周股票复盘：心脉医疗（688016）2025年年度股东会顺利召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2636406422","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636406422?lang=zh_cn&edition=full","pubTime":"2026-05-17 03:45","pubTimestamp":1778960712,"startTime":"0","endTime":"0","summary":"公司公告汇总：会议审议通过2025年年度报告、利润分配预案及续聘会计师事务所等议案。公司公告汇总心脉医疗：北京市嘉源律师事务所关于上海微创心脉医疗科技（集团）股份有限公司2025年年度股东会的法律意见书北京市嘉源律师事务所对上海微创心脉医疗科技(集团)股份有限公司2025年年度股东会的召集、召开程序、出席会议人员资格、召集人资格、表决程序及表决结果进行了见证，并出具法律意见书。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700001168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635715611","title":"心脉医疗（688016）披露2025年年度股东会决议公告，5月14日股价下跌2.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635715611","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635715611?lang=zh_cn&edition=full","pubTime":"2026-05-14 18:20","pubTimestamp":1778754036,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘，心脉医疗报收于103.99元，较前一交易日下跌2.27%，最新总市值为128.18亿元。该股当日开盘105.99元，最高106.11元，最低102.59元，成交额达2.23亿元，换手率为1.74%。近日，心脉医疗发布《2025年年度股东会决议公告》。公告显示，公司于2026年5月13日召开2025年年度股东会，会议由董事长孙洪斌主持，采用现场与网络投票结合方式召开，出席会议股东及代理人共133人，代表有表决权股份总数的43.0693%。所有议案均获有效通过，无被否决议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400034878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632069352","title":"【机构调研记录】蜂巢基金调研心脉医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2632069352","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2632069352?lang=zh_cn&edition=full","pubTime":"2026-05-01 08:03","pubTimestamp":1777593801,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及4月30日披露的机构调研信息，蜂巢基金近期对1家上市公司进行了调研，相关名单如下：1）心脉医疗 调研纪要：报告期内，公司实现营业总收入37,023.62万元，同比增长11.45%；归母净利润15,484.19万元，同比增长19.44%。蜂巢基金成立于2018年，截至目前，资产管理规模342.19亿元，排名99/212；资产管理规模342.19亿元，排名88/212；管理公募基金数57只，排名102/212；旗下公募基金经理9人，排名113/212。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100008223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632527693","title":"【机构调研记录】东海基金调研爱博医疗、心脉医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2632527693","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2632527693?lang=zh_cn&edition=full","pubTime":"2026-05-01 08:01","pubTimestamp":1777593687,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及4月30日披露的机构调研信息，东海基金近期对2家上市公司进行了调研，相关名单如下：1）爱博医疗 个股亮点：公司已自主开发普诺瞳 AI数字验配系统。2）心脉医疗 调研纪要：报告期内，公司实现营业总收入37,023.62万元，同比增长11.45%；归母净利润15,484.19万元，同比增长19.44%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100008050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2460026573.USD","BK0251","688016","688050"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631352684","title":"心脉医疗(688016)3月31日股东户数1.63万户，较上期增加6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631352684","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2631352684?lang=zh_cn&edition=full","pubTime":"2026-04-30 17:32","pubTimestamp":1777541570,"startTime":"0","endTime":"0","summary":"证券之星消息，近日心脉医疗披露，截至2026年3月31日公司股东户数为1.63万户，较2月28日增加991.0户，增幅为6.47%。在医疗器械行业个股中，心脉医疗股东户数低于行业平均水平，截至3月31日，医疗器械行业平均股东户数为2.21万户。从股价来看，2026年2月28日至2026年3月31日，心脉医疗区间涨幅为0.04%，在此期间股东户数增加991.0户，增幅为6.47%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000056358.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631152879","title":"图解心脉医疗一季报：第一季度单季净利润同比增长19.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631152879","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2631152879?lang=zh_cn&edition=full","pubTime":"2026-04-30 03:32","pubTimestamp":1777491136,"startTime":"0","endTime":"0","summary":"证券之星消息，心脉医疗2026年一季报显示，一季度公司主营收入3.7亿元，同比上升11.45%；归母净利润1.55亿元，同比上升19.44%；扣非净利润1.51亿元，同比上升23.14%；负债率11.57%，投资收益250.36万元，财务费用156.27万元，毛利率73.13%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000009699.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631592298","title":"微创医疗(00853)：心脉医疗科技第一季度股东应占净利润1.55亿元 同比增加19.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631592298","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2631592298?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:40","pubTimestamp":1777459211,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微创医疗(00853)发布上海微创心脉医疗科技(集团)股份有限公司2026年第一季度业绩，该公司取得收入人民币3.7亿元(单位下同)，同比增加11.45%;归属于心脉医疗科技股权持有人的净利润1.55亿元，同比增加19.44%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436364.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688016","00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625608717","title":"股市必读：心脉医疗（688016）4月3日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2625608717","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2625608717?lang=zh_cn&edition=full","pubTime":"2026-04-07 01:08","pubTimestamp":1775495294,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，心脉医疗报收于99.68元，下跌2.83%，换手率1.63%，成交量2.02万手，成交额2.02亿元。当日关注点来自交易信息汇总：4月3日主力资金净流出2975.4万元，占总成交额14.71%。机构调研要点4月2日召开2025年年度业绩电话会，心脉医疗就2026年4月2日投资者关系活动主要内容进行说明。公告详情请查看附件。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700000527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625729625","title":"【机构调研记录】蜂巢基金调研心脉医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2625729625","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2625729625?lang=zh_cn&edition=full","pubTime":"2026-04-06 08:02","pubTimestamp":1775433757,"startTime":"0","endTime":"0","summary":"蜂巢基金成立于2018年，截至目前，资产管理规模417.91亿元，排名91/212；资产管理规模417.91亿元，排名83/212；管理公募基金数57只，排名102/212；旗下公募基金经理9人，排名113/212。旗下最近一年表现最佳的公募基金产品为蜂巢先进制造混合发起式A，最新单位净值为1.47，近一年增长51.59%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040600000277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625625046","title":"【机构调研记录】红塔红土调研心脉医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2625625046","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2625625046?lang=zh_cn&edition=full","pubTime":"2026-04-06 08:02","pubTimestamp":1775433756,"startTime":"0","endTime":"0","summary":"红塔红土成立于2012年，截至目前，资产管理规模104.11亿元，排名142/212；资产管理规模85.89亿元，排名125/212；管理公募基金数34只，排名122/212；旗下公募基金经理5人，排名145/212。旗下最近一年表现最佳的公募基金产品为红塔红土信息产业精选股票发起式A，最新单位净值为2.06，近一年增长44.54%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040600000274.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625625086","title":"【机构调研记录】惠升基金调研道恩股份、心脉医疗等3只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2625625086","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2625625086?lang=zh_cn&edition=full","pubTime":"2026-04-06 08:02","pubTimestamp":1775433738,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及4月3日披露的机构调研信息，惠升基金近期对3家上市公司进行了调研，相关名单如下：1）道恩股份 调研纪要：2025年，公司实现营业收入605,592.34万元，同比增长14.25%；归母净利润18,890.35万元，同比增长34.03%；产品销量突破55.61万吨，创历史新高。惠升基金成立于2018年，截至目前，资产管理规模540.47亿元，排名87/212；资产管理规模540.47亿元，排名76/212；管理公募基金数51只，排名105/212；旗下公募基金经理11人，排名103/212。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040600000248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0220","BK0251","002838","688016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625616340","title":"每周股票复盘：心脉医疗（688016）Q4净利增362.05%、股东户数降4.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625616340","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2625616340?lang=zh_cn&edition=full","pubTime":"2026-04-05 01:51","pubTimestamp":1775325069,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，心脉医疗报收于99.68元，较上周的104.58元下跌4.69%。本周，心脉医疗3月30日盘中最高价报107.1元。股本股东变化股东户数变动截至2026年2月28日，公司股东户数为1.53万户，较12月31日减少706.0户，减幅为4.41%。户均持股数量由上期的7691.0股增加至8046.0股，户均持股市值为81.67万元。2025年第四季度单季度主营收入3.36亿元，同比上升41.85%；单季度归母净利润1.34亿元，同比上升362.05%；单季度扣非净利润1.3亿元，同比上升222.15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500000341.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688016"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788011894747,"stockEarnings":[{"period":"1week","weight":-0.022},{"period":"1month","weight":-0.0361},{"period":"3month","weight":-0.1058},{"period":"6month","weight":-0.1002},{"period":"1year","weight":-0.1609},{"period":"ytd","weight":-0.0035}],"compareEarnings":[{"period":"1week","weight":0.012},{"period":"1month","weight":0.0323},{"period":"3month","weight":-0.0286},{"period":"6month","weight":-0.0506},{"period":"1year","weight":0.0283},{"period":"ytd","weight":-0.0042}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海微创心脉医疗科技(集团)股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"16203人(较上一季度减少0.66%)","perCapita":"7607股","listingDate":"2019-07-22","address":"上海市浦东新区康新公路3399弄1号","registeredCapital":"12326万元","survey":" 上海微创心脉医疗科技(集团)股份有限公司的主营业务是主动脉及外周血管介入医疗器械的研发、生产、销售和服务。公司的主要产品是胸主动脉和腹主动脉覆膜支架、术中支架、外周血管支架、药物球囊扩张导管、球囊扩张导管、腔静脉滤器及滤器回收器、血栓切除装置、肿瘤栓塞微球。公司获得了2025上海专精特新企业品牌价值100强称号。","listedPrice":46.23},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"心脉医疗(688016)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供心脉医疗(688016)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"心脉医疗,688016,心脉医疗股票,心脉医疗股票老虎,心脉医疗股票老虎国际,心脉医疗行情,心脉医疗股票行情,心脉医疗股价,心脉医疗股市,心脉医疗股票价格,心脉医疗股票交易,心脉医疗股票购买,心脉医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"心脉医疗(688016)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供心脉医疗(688016)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}